Compare MOVE & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOVE | ATRC |
|---|---|---|
| Founded | 2018 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2021 | 2005 |
| Metric | MOVE | ATRC |
|---|---|---|
| Price | $21.54 | $27.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $51.17 |
| AVG Volume (30 Days) | 65.0K | ★ 760.5K |
| Earning Date | 04-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | N/A | ★ N/A |
| Revenue | $433,000.00 | ★ $201,630,000.00 |
| Revenue This Year | $1,460.71 | $15.27 |
| Revenue Next Year | $96.77 | $12.21 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $0.52 | $25.36 |
| 52 Week High | $34.87 | $43.18 |
| Indicator | MOVE | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 56.23 | 46.85 |
| Support Level | $6.77 | $26.47 |
| Resistance Level | $25.90 | $30.49 |
| Average True Range (ATR) | 2.75 | 1.28 |
| MACD | -0.19 | -0.13 |
| Stochastic Oscillator | 42.53 | 46.70 |
Corvex Inc is an AI cloud computing company that provides computing infrastructure for artificial intelligence workloads, including GPU-accelerated computing, confidential computing, and inference services. Its offerings are used by government and enterprise customers, including those with regulated workloads, to support the deployment and operation of AI models and data processing systems. The company generates revenue from the sale of Wellness Rings, portable chargers and charging cables, ring sizers, and mobile applications.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.